Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Hanmi Pharmaceutical has launched Countmate, a fully automated vial dispensing machine designed to meet the specific needs of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...

As industry shifts to maximising AI's potential, five trends will redefine pharma in the coming years. Accelerating drug discovery with AI and machine learning (ML) In the pharmaceutical and ...

In 2025, pharma companies must enable an instantaneous ... transformation in 2025 requires artificial intelligence and machine learning. This allows rapid identification of high-potential segments ...